Are respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx?

References

• Marfin AA, Price TH. Granulocyte Transfusion Therapy. J Intensive Care Med 2013; Forthcoming http://dx.doi.org/10.1177/0885066613498045; PMID: 23920161
   PubMed Web of Science ®Google Scholar
• Freireich EJ. Leukocyte transfusion and the development of the continuous-flow blood cell separator. Transfus Med Rev 2011; 25:344 - 50; http://dx.doi.org/10.1016/j.tmrv.2011.04.004; PMID: 21632206
   PubMed Web of Science ®Google Scholar
• Wingard JR, Ribaud P, Schlamm HT, Herbrecht R. Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 2008; 112:2309 - 12; http://dx.doi.org/10.1002/cncr.23441; PMID: 18338758
   PubMed Web of Science ®Google Scholar
• Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, Silling G, Grimminger W, Einsele H. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant 2008; 42:679 - 84; http://dx.doi.org/10.1038/bmt.2008.237; PMID: 18695660
   PubMed Web of Science ®Google Scholar
• Kim KH, Lim HJ, Kim JS, Kim BS, Bang SM, Kim I, Han KS, Kim BK, Lee SM, Yoon SS. Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute. Cytotherapy 2011; 13:490 - 8; http://dx.doi.org/10.3109/14653249.2010.529889; PMID: 21090917
   PubMed Web of Science ®Google Scholar
• Raad II, Chaftari AM, Al Shuaibi MM, Jiang Y, Shomali W, Cortes JE, Lichtiger B, Hachem RY. Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications. Ann Oncol 2013; 24:1873 - 9; http://dx.doi.org/10.1093/annonc/mdt110; PMID: 23519997
   PubMed Web of Science ®Google Scholar
• Hohl TM, Feldmesser M, Perlin DS, Pamer EG. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis 2008; 198:176 - 85; http://dx.doi.org/10.1086/589304; PMID: 18500928
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Lewis RE, Chamilos G, May GS, Safdar A, Walsh TJ, Raad II, Kontoyiannis DP. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008; 198:186 - 92; http://dx.doi.org/10.1086/589305; PMID: 18500936
   PubMed Web of Science ®Google Scholar
• Lewis RE, Liao G, Young K, Douglas C, Kontoyiannis DP. Macrophage Reporter Cell Assay for Screening Immunopharmacological Activity of Cell-Wall Active Antifungals. Antimicrob Agents Chemother 2014; Forthcoming http://dx.doi.org/10.1128/AAC.02408-13; PMID: 24395226
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Lewis RE, Kontoyiannis DP. Immunocompromised hosts: immunopharmacology of modern antifungals. Clin Infect Dis 2008; 47:226 - 35; http://dx.doi.org/10.1086/589290; PMID: 18540822
   PubMed Web of Science ®Google Scholar
• Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem 2003; 278:37561 - 8; http://dx.doi.org/10.1074/jbc.M306137200; PMID: 12860979
   PubMed Web of Science ®Google Scholar
• Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981; 304:1185 - 9; http://dx.doi.org/10.1056/NEJM198105143042001; PMID: 7219459
   PubMed Web of Science ®Google Scholar
• Lewis RE, Chamilos G, Prince RA, Kontoyiannis DP. Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice. Antimicrob Agents Chemother 2007; 51:1078 - 81; http://dx.doi.org/10.1128/AAC.01268-06; PMID: 17194825
   PubMed Web of Science ®Google Scholar
• Kamai Y, Lossinsky AS, Liu H, Sheppard DC, Filler SG. Polarized response of endothelial cells to invasion by Aspergillus fumigatus. Cell Microbiol 2009; 11:170 - 82; http://dx.doi.org/10.1111/j.1462-5822.2008.01247.x; PMID: 19016788
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP. Manipulation of host angioneogenesis: A critical link for understanding the pathogenesis of invasive mold infections?. Virulence 2010; 1:192 - 6; http://dx.doi.org/10.4161/viru.1.3.11380; PMID: 21178441
   PubMed Web of Science ®Google Scholar
• Speth C, Hagleitner M, Ott HW, Würzner R, Lass-Flörl C, Rambach G. Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. J Infect Dis 2013; 207:823 - 33; http://dx.doi.org/10.1093/infdis/jis743; PMID: 23225903
   PubMed Web of Science ®Google Scholar
• Lionakis MS, Fischer BG, Lim JK, Swamydas M, Wan W, Richard Lee CC, Cohen JI, Scheinberg P, Gao JL, Murphy PM. Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathog 2012; 8:e1002865; http://dx.doi.org/10.1371/journal.ppat.1002865; PMID: 22916017
   PubMed Web of Science ®Google Scholar
• Nouailles G, Dorhoi A, Koch M, Zerrahn J, Weiner J 3rd, Faé KC, Arrey F, Kuhlmann S, Bandermann S, Loewe D, et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest 2014; Forthcoming http://dx.doi.org/10.1172/JCI72030; PMID: 24509076
   PubMed Web of Science ®Google Scholar
• Miceli MH, Maertens J, Buvé K, Grazziutti M, Woods G, Rahman M, Barlogie B, Anaissie EJ. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer 2007; 110:112 - 20; http://dx.doi.org/10.1002/cncr.22738; PMID: 17525971
   PubMed Web of Science ®Google Scholar